Although randomized clinical trials and animal studies have confirmed that TCM, specifically Chinese patent medicine, Chinese herbal medicine, and Chinese medicine injection, is effective in treating ischemic stroke [36–39], conventional recombinant tissue plasminogen activator is almost the only approved and available thrombolytic agent used at the onset of acute ischemic stroke [40, 41]. This evidence concerns the gene PLAT and ischemic stroke.